Private Equity Firm Financial Services

SK Capital Partners

New York, New York, United States

SK Capital is a private investment firm with a disciplined focus on specialty materials, ingredients, and life sciences. It seeks buyouts, recapitalizations, and growth equity investments and transforms businesses into higher-performing organizations through active engagement with management teams.

Focus Areas
Specialty materials, Specialty ingredients, Life sciences

Tracked deals

43

43 tracked deals across 2017-2026.

Recent pace

4

4 tracked deals announced in the last 12 months.

Deal mix

Buyout

25 buyout · 9 addon · 3 divestiture

SK Capital Partners Acquisition Volume by Year

Last 9 years

Acquisition volume by year Annual acquisition counts for the last 9 years for SK Capital Partners. 1 2017 1 2019 3 2020 10 2021 10 2022 7 2023 4 2024 5 2025 ~3 est. 2 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

Showing the 12 most recent of 43 tracked deals for SK Capital Partners.

  • Buyer
    SK Capital Partners
    Target
    Apotex Health Corp.
    Seller
    Sherman estate
    Industry
    Pharmaceuticals
    Location
    Canada

    SK Capital Partners acquired control of Apotex from the Sherman estate in 2023, then reoriented the business with cost cuts, geographic focus, and portfolio acquisitions (including biosimilars and specialty drugs). Over the following three years, SK Capital and the Sherman family completed a debt-heavy leveraged buyout and extracted roughly $2 billion via dividends and share repurchases, culminating in Apotex’s IPO in June 2026.

  • Buyer
    SK Capital Partners
    Target
    Brothers International Food Holdings
    Seller
    Benford Capital Partners
    Industry
    Food & Beverage
    Type
    Buyout

    SK Capital Partners’ affiliates completed the acquisition of Brothers International Food Holdings, taking a controlling stake in partnership with founder Travis Betters. Brothers is a global provider of natural fruit ingredients and products for the food and beverage industry, headquartered in Rochester, New York.

  • Buyer
    SK Capital Partners
    Target
    Swixx BioPharma AG
    Location
    Switzerland

    SK Capital Partners, through an affiliate, reached a definitive agreement to invest in Swixx BioPharma AG as the company looks to accelerate its next phase of growth and global expansion. The transaction values Swixx at more than €1.5 billion, with Swixx co-founders and CEO/CFO retaining significant ownership and existing investors HBM Healthcare Investments and Mérieux Equity Partners remaining shareholders.

  • Buyer
    SK Capital Partners, LP
    Target
    Precera Medical
    Seller
    LISI Group
    Industry
    Medical Devices
    Type
    Buyout

    SK Capital Partners has completed the acquisition of LISI Group's Medical division and launched the business as Precera Medical, a precision medical device CDMO headquartered in Big Lake, Minnesota. LISI Group retained a minority stake; SK Capital plans to invest in capacity and capabilities and pursue organic growth and M&A to expand the new platform's service offerings to global medical device OEMs.

  • Buyer
    Carlyle, SK Capital Partners, LP, Beacon Parent Holdings, L.P., Beacon Merger Sub, Inc.
    Target
    bluebird bio, Inc.
    Type
    Buyout

    bluebird bio entered into a definitive agreement to be acquired by funds managed by Carlyle and SK Capital Partners, with expected close in the first half of 2025. Under the deal, bluebird stockholders are set to receive $3.00 per share in cash plus a contingent value right (CVR) of up to $6.84 per share if a net sales milestone is achieved by 2027 (or an alternative $5.00 per share cash option later added).

  • Buyer
    SK Capital Partners
    Target
    Physical Properties Testers Group Limited
    Seller
    Battery Ventures
    Industry
    Manufacturing
    Location
    West Yorkshire, United Kingdom
    Type
    Buyout

    Funds advised by SK Capital Partners completed the acquisition of Physical Properties Testers Group (PPT Group) from Battery Ventures. PPT Group, headquartered in Halifax, United Kingdom, is a manufacturer of material test and measurement instruments with global operations and roughly 280 employees; SK Capital said it will grow the business organically and via M&A while onboarding Jim Neville as Global CEO.

  • Buyer
    GEON Performance Solutions, SK Capital Partners
    Target
    Foster Corporation
    Industry
    Medical Devices
    Type
    Buyout

    GEON Performance Solutions, a portfolio company of SK Capital Partners, acquired Foster Corporation, a compounder of biomedical polymers used in the medical device and healthcare markets. The acquisition expands GEON’s medical polymer portfolio and manufacturing capacity—Foster is headquartered in Putnam, Connecticut, operates three U.S. manufacturing sites and two distribution centers, and employs approximately 200 people.

  • Buyer
    SK Capital Partners, Stellus Capital Management
    Target
    Spectra Confectionery Ltd.
    Seller
    Bill and Maureen Georgas and the Georgas family
    Industry
    Food & Beverage
    Location
    Ontario, Canada
    Type
    Buyout

    Funds advised by SK Capital Partners acquired Spectra Confectionery Ltd., a Toronto-area manufacturer of premium decorative toppings and confectionery products, from founders Bill and Maureen Georgas. Debt financing was provided by MidStar Capital and unitranche financing (with an equity co-investment) was provided by Stellus Capital Management; Spectra's leadership (the Georgas family) will remain in place to run day-to-day operations.

  • Buyer
    SK Capital Partners & Affiliates
    Target
    SI Group
    Industry
    Manufacturing

    SI Group completed a private debt exchange (Sept. 18) with a concurrent public offer, receiving participation from ~100% of first‑lien lenders and 89% of unsecured noteholders. The transaction extends maturities to 2028, secures a new $218M revolving credit facility, reduces interest expense and includes a $150M new‑money investment from SK Capital Partners and affiliates to bolster liquidity and repay debt.

  • Buyer
    SK Capital Partners
    Target
    North America Composites & Fuel Containment Division (Parker Hannifin) / Axillon Aerospace
    Seller
    Parker Hannifin Corporation

    SK Capital Partners has signed a definitive agreement to acquire the North America Composites & Fuel Containment (CFC) Division of Parker Hannifin and completed the acquisition, renaming the business Axillon Aerospace. The division is a leading producer of engineered carbon fiber composite components and fuel containment solutions for defense and commercial aerospace, generating about $350 million in annual sales, operating six North American manufacturing sites, and employing ~1,700 people.

  • Buyer
    Luxium Solutions, LLC, SK Capital Partners, Edgewater Capital Partners
    Target
    Inrad Optics, Inc.
    Seller
    Clarex, Ltd., Welland, Ltd.
    Industry
    IT Services
    Type
    Buyout

    Luxium Solutions has completed its all-cash acquisition of Inrad Optics in a deal valued at approximately $19 million (including assumed debt). Under the terms of the definitive merger agreement, Inrad Optics stockholders received $1.10 per share in cash, and the transaction strengthens Luxium’s portfolio in optics and photonics solutions.

  • Buyer
    SK Capital Partners
    Target
    J&K Ingredients
    Seller
    CORE Industrial Partners
    Industry
    Food & Beverage
    Type
    Buyout

    Funds advised by SK Capital Partners have acquired J&K Ingredients from CORE Industrial Partners. The acquisition, completed November 20, 2023, positions SK Capital to build a clean-label food & beverage ingredients platform around J&K's specialty preservative and bakery ingredient capabilities; debt financing was provided by KeyBanc Capital Markets, Kayne Anderson Private Credit, and Benefit Street Partners.

Related Acquisition Pages

Selling a company? Get in front of buyers like SK Capital Partners

Turn tracked acquisition activity into an outreach-ready buyer list.